Redmile Group, LLC Portfolio Holdings

Redmile Group, LLC

  • $1.53 Billion
  • Q2 2024

Redmile Group, LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $1.53 Billion distributed in 63 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Krystal Biotech, Inc. with a value of $188M, Amicus Therapeutics, Inc. with a value of $105M, Nurix Therapeutics, Inc. with a value of $92.3M, Stoke Therapeutics, Inc. with a value of $63.8M, and Immunome Inc. with a value of $59.2M.

Examining the 13F form we can see an decrease of $1B in the current position value, from $2.54B to 1.53B.

Redmile Group, LLC is based out at San Francisco, CA

Below you can find more details about Redmile Group, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.53 Billion
Healthcare: $1.52 Billion

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.1B
$92.3 Million 6.02% of portfolio
4,423,616
Q2 2024 Reduced 1.33%
$579M
$63.8 Million 4.16% of portfolio
4,721,054
Q2 2024 Reduced 6.94%
$496M
$53.5 Million 3.49% of portfolio
4,569,802
Q2 2024 Added 0.4%
$511M
$50.1 Million 3.26% of portfolio
5,562,096
Q2 2024 Added 49.12%
$415M
$45.4 Million 2.96% of portfolio
5,453,083
Q2 2024 Reduced 15.06%
$329M
$43.2 Million 2.82% of portfolio
13,169,057
Q4 2023 Added 0.34%
$688M
$40.5 Million 2.64% of portfolio
4,799,973
Q2 2024 Added 21.13%
$1.64B
$39.9 Million 2.6% of portfolio
1,703,061
Q2 2024 Reduced 9.39%
$669M
$38.3 Million 2.5% of portfolio
2,014,296
Q2 2024 Reduced 0.66%
$1.23B
$37.9 Million 2.47% of portfolio
1,614,473
Q2 2024 Reduced 13.14%
$627M
$34.5 Million 2.25% of portfolio
3,209,591
Q2 2024 Added 3.63%
$1.74B
$26.7 Million 1.74% of portfolio
759,516
Q2 2024 Reduced 17.68%
$373M
$25.4 Million 1.66% of portfolio
8,253,316
Q1 2024 Added 2.77%
$1.35B
$25.2 Million 1.65% of portfolio
552,506
Q1 2024 New
$488M
$22.5 Million 1.47% of portfolio
1,073,435
Q2 2024 Reduced 14.9%
$866M
$13.9 Million 0.91% of portfolio
1,881,501
Q2 2024 Reduced 14.27%
$359M
$10.7 Million 0.7% of portfolio
2,074,350
Q1 2024 Added 56.63%
$505M
$10.1 Million 0.66% of portfolio
3,065,714
Q2 2024 Added 112.79%
$1.01B
$9.68 Million 0.63% of portfolio
213,024
Q2 2024 Added 86.31%
$606M
$8.85 Million 0.58% of portfolio
3,031,009
Q3 2022 Reduced 12.69%
$464M
$7.99 Million 0.52% of portfolio
560,971
Q2 2024 Reduced 56.3%
$336M
$7.14 Million 0.47% of portfolio
1,463,406
Q2 2024 Reduced 8.79%
$341M
$2.35 Million 0.15% of portfolio
1,046,587
Q4 2021 New

Summary

  • Portfolio
  • No. of Stocks 63
  • Current Value $1.53 Billion
  • Prior Value $2.54 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 1 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 34 stocks
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email